ASCVD Calculator
ASCVD risk is the chance that someone who has never had a heart attack or stroke will have a first one in the next 10 years, and it is the number US guidelines use to frame statin and blood pressure conversations. This calculator runs both models a clinician might use: the AHA PREVENT equations from 2023, which are race-free and include kidney function, and the older 2013 Pooled Cohort Equations, kept so you can compare a new result with one from a past visit. It is an educational estimate, not medical advice: never start or stop a medication because of a percentage on a website. Excess weight drives several of these risk factors at once — blood pressure, cholesterol and diabetes risk — so a BMI weight loss calculator can help you set a realistic target before you rerun your numbers.
PCE: Goff et al., Circulation 2014 (ages 40-79). PREVENT: Khan et al., Circulation 2024 (ages 30-79). Educational estimate only, not medical advice. Nothing you enter leaves your browser.
Quick Answer
This calculator estimates 10-year ASCVD risk (a first heart attack, stroke, or cardiovascular death) with the two guideline models: AHA PREVENT 2023 and the 2013 Pooled Cohort Equations. The pre-filled example, a 55-year-old woman with total cholesterol 180 mg/dL, HDL 60, systolic BP 115 untreated, no smoking or diabetes, and eGFR 90, scores 1.4% on PREVENT, rated Low risk, and 1.3% on PCE with the same inputs.
Key takeaways
- Two models, one page: PREVENT 2023 is the current, race-free AHA model and adds kidney function; PCE 2013 is the legacy model many older results were computed with.
- The band drives the conversation, not the decimal: under 3% is low on PREVENT, 5% and above is where a prevention discussion usually starts.
- Out-of-range inputs get an honest error, not an extrapolated guess: PCE covers ages 40 to 79, PREVENT ages 30 to 79.
- PREVENT results include a what-if table, so you can see what quitting smoking or a 10-point blood pressure drop would do before you talk to a clinician.
- Quick Answer
- How to use this ASCVD calculator
- Worked example: one woman, both models, checked against this tool
- PCE vs PREVENT: which model should you look at?
- The formulas, in plain form
- What the equations cannot see
- Risk bands at a glance
- Which inputs move the number most
- What a 7.5% risk means in plain numbers
- Why your number can move between visits
- What competing calculators miss
- Frequently asked questions
- Add This Calculator to Your Website
- References
How to use this ASCVD calculator
Pick a model, enter the numbers from your most recent labs and blood pressure check, and click Calculate. The result stays hidden until you calculate, and nothing you type leaves your browser.
- Choose the model: PREVENT 2023 is the default and the one the AHA now recommends. Switch to PCE 2013 only to compare against an older result or a clinic printout that used it.
- Enter age, cholesterol, and blood pressure: total cholesterol and HDL come from a lipid panel; systolic pressure is the top number of a reading such as 120/80. Both models refuse values outside their validated ranges (for example total cholesterol 130 to 320 mg/dL) rather than extrapolating.
- Answer the yes or no questions honestly: blood pressure treatment, current smoking, and diabetes are inputs, not judgements, and each one moves the estimate by a clinically real amount.
- In PREVENT mode, add kidney function if you have it: enter eGFR from a lab report, or enter serum creatinine and the tool estimates eGFR with the race-free CKD-EPI 2021 equation published by Inker and colleagues in the New England Journal of Medicine. A creatinine entry overrides the eGFR field.
- Read the band, then the what-if table: the percentage, the risk band, your TC:HDL ratio, and your blood pressure category come first. Under a PREVENT result, the scenario table shows your risk if one factor changed at a time.
One scope note worth knowing before you start: this page runs the base PREVENT model. The full PREVENT equations have optional add-ons (hemoglobin A1c, urine albumin-to-creatinine ratio, and a social deprivation index) that this tool does not ask for, and it reports 10-year ASCVD risk only, not the 30-year, total cardiovascular disease, or heart failure estimates the official AHA tool can also produce.
Worked example: one woman, both models, checked against this tool
The pre-filled inputs are a 55-year-old woman: total cholesterol 180, HDL 60, systolic BP 115 (untreated), non-smoker, no diabetes, eGFR 90. Clicking Calculate on PREVENT gives 1.4%, Low risk (PREVENT 2023), with a TC:HDL ratio of 3.00:1 and a Normal blood pressure category. Switching the model to PCE with the same inputs gives 1.3%, Low risk (PCE 2013). At low risk the two models nearly agree; they pull apart as risk rises, which the second profile in the checks table below shows.
Every row in this table is a real run of the calculator above, so you can reproduce each one exactly:
| Profile | Model | 10-year risk | Band |
|---|---|---|---|
| Woman, 55, TC 180, HDL 60, SBP 115, no risk factors, eGFR 90 | PREVENT | 1.4% | Low |
| Same woman, same inputs | PCE | 1.3% | Low |
| Man, 60, TC 220, HDL 40, SBP 150 treated, smoker, diabetes, eGFR 60 | PREVENT | 19.4% | High |
| Woman, 45, TC 200, HDL 50, SBP 120, creatinine 1.0 (eGFR estimated at 71) | PREVENT | 0.9% | Low |
| Man, 79, TC 200, HDL 50, SBP 130, no other risk factors | PCE | 31.8% | High |
PCE vs PREVENT: which model should you look at?
Look at PREVENT first. It is the model the American Heart Association now recommends, it drops race from the math, and it uses kidney function and statin use that PCE never sees. Keep PCE for comparison with older results.
The Pooled Cohort Equations, published by Goff and colleagues in Circulation in 2014, were built from US cohorts enrolled decades ago and carry four separate coefficient sets: White women, White men, African American women, African American men. The PREVENT equations, published by Khan and colleagues in Circulation in 2024, were derived from more than 3 million contemporary adults, are sex-specific but race-free, and add eGFR because kidney disease turned out to carry cardiovascular information the older variables missed. Because the newer cohort had lower event rates, PREVENT usually returns a lower number for the same person. That is recalibration, not a discount: studies comparing the two find a large share of PCE intermediate-risk adults reclassify downward on PREVENT.
One thing neither model gives you is a lifetime view. A 35-year-old can score low over 10 years and still carry high lifetime risk, which is part of why blood pressure control compounds over decades: the blood pressure life expectancy calculator puts that long-horizon trade into years instead of percentages.
The formulas, in plain form
PCE is a survival equation: risk = 1 − S10 raised to the power of exp(your weighted sum − the group mean), where the weights are the published coefficients for your sex and race group and every input enters as a natural logarithm. PREVENT is a logistic equation: risk = ex ÷ (1 + ex), where x combines age, cholesterol, blood pressure, kidney function, diabetes, smoking, and treatment terms, each centered on a reference value (age 55, non-HDL cholesterol 3.5 mmol/L, eGFR 90) before its coefficient is applied.
Two implementation details matter for trusting the numbers. First, cholesterol enters PREVENT in mmol/L, converted from your mg/dL entry, because the published coefficients are scaled that way; a missed conversion is the most common bug in home-made PREVENT copies, and it inflates risk badly. Second, the creatinine option uses the CKD-EPI 2021 equation without a race coefficient, exactly as its authors published it, so a creatinine of 1.0 mg/dL for the 45-year-old woman in the checks table gives eGFR 71, and the tool tells you it estimated the value rather than letting you guess.
What the equations cannot see
Both models are blind to risk-enhancing factors: family history of early heart disease, lipoprotein(a), chronic inflammatory conditions, pregnancy complications such as preeclampsia, and lifelong exposure to high cholesterol. Guidelines tell clinicians to weigh exactly those factors when a result sits near a treatment threshold, which is why a 6.9% and a 7.6% PCE result can lead to the same decision in a real visit.
The models also assume you have never had a cardiovascular event. They are primary-prevention equations. If you already have atrial fibrillation, stroke prevention runs through a different score entirely, the one in the CHA2DS2-VASc calculator, and if you have known heart disease your clinician is managing established disease, not estimating a first event. Treat any percentage from this page as the start of that conversation. The US Preventive Services Task Force statin recommendation is a good example of how the number is meant to be used: as one input to a shared decision, never as the decision itself.
Risk bands at a glance
The two models slice the same 0 to 100% scale at different points. These are the bands this tool reports, and the thresholds match the categories US guidelines discuss for each model.
| Band | PCE 2013 | PREVENT 2023 | What it usually means |
|---|---|---|---|
| Low | Under 5% | Under 3% | Keep up heart-healthy habits, reassess in 4 to 6 years |
| Borderline | 5% to under 7.5% | 3% to under 5% | Lifestyle first; risk-enhancing factors tip the discussion |
| Intermediate | 7.5% to under 20% | 5% to under 10% | Clinician discussion about preventive therapy |
| High | 20% or more | 10% or more | Prompt clinician review and active risk-factor management |
Which inputs move the number most
Age is the strongest term in both equations and the one input you cannot change. Among the levers you control, smoking status and systolic pressure move the estimate most, diabetes is close behind, and cholesterol changes are real but smaller point for point.
The what-if table under a PREVENT result proves it with your own numbers. For the 60-year-old man in the checks table (PREVENT 19.4%), the scenarios come out as: quit smoking, 14.5% (4.9 points lower); HDL 10 mg/dL higher, 17.5% (1.9 points lower); systolic pressure 10 mm Hg lower, 17.5% (1.8 points lower); total cholesterol 20 mg/dL lower, 18.2% (1.2 points lower); kidney function at eGFR 90 instead of 60, 18.8% (0.6 points lower). One honest caveat: the scenarios are arithmetic, not promises. They change one input and hold the rest fixed, and they do not re-check the changed value against the validated ranges, so read them for direction and rough size, then set real targets with a clinician.
What a 7.5% risk means in plain numbers
A 7.5% ten-year risk means roughly 7 or 8 people out of 100 with your profile will have a heart attack, stroke, or cardiovascular death in the next decade, and 92 or 93 will not. It is not a 7.5% chance each year, and it says nothing about which side of the line you personally land on.
The 7.5% figure became famous because the cholesterol guidelines used it as the PCE discussion threshold: the point where, on average across a population, the expected benefit of a statin starts to outweigh its downsides for most people. The 2018 AHA/ACC cholesterol guideline pairs that threshold with risk-enhancing factors and a clinician-patient discussion rather than an automatic prescription, and PREVENT’s lower thresholds (5% for the discussion zone) reflect its lower, recalibrated estimates. If your result sits just under a threshold, you do not have a different body than someone just over it. You have the same risk and a rounding boundary, which is exactly why the band and the enhancers matter more than the decimal.
Why your number can move between visits
Your estimate can shift several points between visits with no real change in your health. Blood pressure varies by time of day, cuff size, and how rushed the measurement was; cholesterol drifts a few percent between labs and with recent illness; and a quit-smoking month or a new prescription rewrites inputs directly.
That volatility matters most near the thresholds, so if a result lands close to 5% or 7.5%, the right move is to recheck the inputs, starting with a repeated, properly taken blood pressure reading, before reading meaning into which side you fell on. Reassess about every 4 to 6 years when risk is low, and sooner after a major change: a new diabetes diagnosis, starting treatment, or quitting smoking. When you rerun the estimate, run it fresh with the new numbers rather than trying to remember last year’s.
What competing calculators miss
Most ASCVD pages on the web still run only the 2013 equations, and several get the details quietly wrong. The gaps that matter:
- PCE-only tools (the majority, including older clinic favourites): no PREVENT at all, so no kidney function, no statin term, and race baked into every result. You get the 2013 answer to a 2026 question.
- The official ACC estimator: genuinely comprehensive, with lifetime risk and therapy-effect modelling, but built for clinicians mid-consult: dense, app-oriented, and it assumes someone will explain the output to you. The AHA’s own PREVENT page is cleaner but reports PREVENT only, with no PCE comparison for an old result.
- Clinician calculators such as ClinCalc: excellent validation and extras like optimal-risk comparisons, written for professionals. The language, and the assumptions about what you already know, follow that audience.
- Tools that extrapolate silently: enter age 25 or cholesterol 400 into many web copies and they happily return a precise-looking percentage from equations never validated there. This tool refuses, with the specific range you crossed.
- The gap this page fills: both guideline models side by side with published coefficients, a creatinine-to-eGFR conversion built in, a what-if table that turns one percentage into a plan, and plain-language bands. For contrast, emergency-department tools such as the HEART score calculator grade chest pain that is already happening; this page estimates a first event years ahead, which is a different job entirely.
Frequently asked questions
Under 5% on the Pooled Cohort Equations, or under 3% on PREVENT, counts as low risk. A PCE result of 7.5% or higher, or a PREVENT result of 5% or higher, is usually where guidelines suggest a clinician discussion about preventive treatment. The band matters more than the decimal: borderline and intermediate results are where risk-enhancing factors and your own preferences carry the most weight.
They are well calibrated for populations and imperfect for any one person. Both models were built from large US study cohorts and predict group event rates closely, but neither can see a family history of early heart disease, lipoprotein(a), chronic inflammation, or decades of exposure, which is why guidelines pair the number with those risk-enhancing factors before any treatment decision.
They come from different derivation cohorts and use different predictors. PREVENT is race-free, adds kidney function (eGFR), statin use, and finer blood-pressure terms, and its more recent cohort had lower event rates, so PREVENT usually estimates lower than PCE for the same person. A gap of a few points between the two is expected, not a sign that one of them is broken.
PCE covers ages 40 to 79 and PREVENT covers ages 30 to 79. Outside those ranges this tool shows an error instead of extrapolating, because neither equation was derived or validated on younger or older adults.
Yes, by moving the inputs themselves: controlling blood pressure, improving cholesterol, not smoking, managing diabetes, and staying active. When the underlying numbers genuinely improve, the lower estimate reflects real risk reduction, not score gaming. Use the what-if table under a PREVENT result to see which single change buys the most, then discuss targets with a clinician.
No. The tool never prescribes, and its guidance lines only describe what guidelines generally discuss at each risk band. A real statin decision also weighs risk-enhancing factors, sometimes a coronary calcium score, side-effect concerns, and your own preference, which only a clinician who knows your history can balance.
eGFR is the estimated glomerular filtration rate, a measure of how well the kidneys filter blood, reported in mL/min/1.73 m². Kidney dysfunction raises cardiovascular risk on its own, so PREVENT includes it as a predictor. Enter a lab eGFR directly, or enter serum creatinine and the tool estimates eGFR with the race-free CKD-EPI 2021 equation.
Guidelines suggest reassessment about every 4 to 6 years for low-risk adults, and sooner after a major change: quitting smoking, starting blood pressure or cholesterol treatment, or a new diabetes diagnosis. If a result lands near a decision threshold, repeat the measurements first, because one blood pressure reading can move the estimate across the line by itself.
No. Every calculation runs in your browser on this page. Nothing you enter is sent to a server, saved, or tracked, and the Copy and Share buttons only do anything when you click them.
Neither is right in an absolute sense: every risk model is an estimate built from a different study population. US clinicians mostly use PCE or PREVENT, UK clinicians use QRISK, and each weights the same inputs slightly differently, so a point or two of disagreement is normal. What matters is the band you land in, low, borderline, intermediate, or high, not the exact decimal. Bring both numbers to your visit and let your clinician reconcile them with the factors no equation can see.
Add This Calculator to Your Website
Embed this calculator on your own site with the code below. Pick a size to preview it live, then copy the code.
Powered by Calculator Zilo
References
- Goff, D.C. Jr. et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk, Circulation. Accessed October 24, 2026.
- Khan, S.S. et al. Development and Validation of the American Heart Association’s PREVENT Equations, Circulation. Accessed October 24, 2026.
- Grundy, S.M. et al. 2018 AHA/ACC Guideline on the Management of Blood Cholesterol, Circulation. Accessed October 24, 2026.
- Inker, L.A. et al. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race, New England Journal of Medicine. Accessed October 24, 2026.
- American Heart Association. PREVENT Cardiovascular Risk Calculator. Accessed October 24, 2026.
- U.S. Preventive Services Task Force. Statin Use in Adults: Preventive Medication. Accessed October 24, 2026.
- National Heart, Lung, and Blood Institute. Heart-Healthy Living. Accessed October 24, 2026.
- National Kidney Foundation. Estimated Glomerular Filtration Rate (eGFR). Accessed October 24, 2026.
- National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes health information. Accessed October 24, 2026.
- MedlinePlus. Cholesterol. Accessed October 24, 2026.
